NKG2D in NK and T cell-mediated immunity

被引：94
作者：
Ogasawara, K
Lanier, LL
机构：
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA
[3] Int Med Ctr Japan, Dept Intractable Dis, Div Clin Immunol, Res Inst,Shinjuku Ku, Tokyo, Japan
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2005年 / 25卷 / 06期
基金：
美国国家卫生研究院;
关键词：
NK cells; NKG2D; DAP10; RAE-1; MICA; autoimmunity; bone marrow transplantation; T cell;
D O I：
10.1007/s10875-005-8786-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
One of the best characterized NK cell receptors is NKG2D, a highly conserved C-type lectin-like membrane glycoprotein expressed on essentially all NK cells, as well as on gamma delta-TcR+ T cells and alpha beta-TcR+ CD8(+) T cells, in humans and mice. Here we review recent studies implicating NKG2D in T cell and NK cell-mediated immunity to viruses and tumors, and its potential role in autoimmune diseases and allogeneic bone marrow transplantation.
引用
收藏
页码：534 / 540
页数：7
相关论文
共 74 条
  • [61] Requirements of NK cells and proinflammatory cytokines in T cell-dependent neonatal autoimmune ovarian disease triggered by immune complex
    Setiady, YY
    Pramoonjago, P
    Tung, KSK
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (02) : 1051 - 1058
  • [62] Natural killer cells determine the out-come of B cell-mediated autoimmunity
    Shi, FD
    Wang, HB
    Li, HL
    Hong, S
    Taniguchi, M
    Link, H
    Van Kaer, L
    Ljunggren, HG
    [J]. NATURE IMMUNOLOGY, 2000, 1 (03) : 245 - 251
  • [63] Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages
    Sirén, J
    Sareneva, T
    Pirhonen, J
    Strengell, M
    Veckman, V
    Julkunen, L
    Matikainen, S
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 2357 - 2364
  • [64] NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
    Smyth, MJ
    Swann, J
    Kelly, JM
    Cretney, E
    Yokoyama, WM
    Diefenbach, A
    Sayers, TJ
    Hayakawa, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (10) : 1325 - 1335
  • [65] NKG2D function protects the host from tumor initiation
    Smyth, MJ
    Swann, J
    Cretney, E
    Zerafa, N
    Yokoyama, WM
    Hayakawa, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) : 583 - 588
  • [66] IL-21 enhances tumor rejection through a NKG2D-dependent mechanism
    Takaki, R
    Hayakawa, Y
    Nelson, A
    Sivakumar, PV
    Hughes, S
    Smyth, MJ
    Lanier, LL
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (04) : 2167 - 2173
  • [67] Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein
    Welte, SA
    Sinzger, C
    Lutz, SZ
    Singh-Jasuja, H
    Sampaio, KL
    Eknigk, U
    Rammensee, HG
    Steinle, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) : 194 - 203
  • [68] Cutting edge:: Novel priming of tumor-speciftic immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway
    Westwood, JA
    Kelly, JM
    Tanner, JE
    Kershaw, MH
    Smyth, MJ
    Hayakawa, Y
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (02) : 757 - 761
  • [69] Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
    Wiemann, K
    Mittrücker, HW
    Feger, U
    Welte, SA
    Yokoyama, WM
    Spies, T
    Rammensee, HG
    Steinle, A
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (02) : 720 - 729
  • [70] Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein
    Wu, J
    Chalupny, NJ
    Manley, TJ
    Riddell, SR
    Cosman, D
    Spies, T
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (08) : 4196 - 4200
12345678